Delivery Order SPE2DB20D3101-SPE2DB24FQUD7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,003.82 firm fixed-price delivery order is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 14, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $8,037.58 for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award was made by the Defense Logistics Agency (DLA), a major procurement agency for the Department of Defense (DoD), and has an ultimate completion date of August 15, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,294.90 Firm Fixed Price delivery order is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has an ultimate completion date of April 11, 2022 and was awarded on April 8, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a larger...
- This federal contract award, with ID SPE2DX15D3007|SPE2DX24F9G3V, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,018.16 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a completion date of November 7, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,387.34 and a performance period ending on January 30, 2024. The contract is a Firm Fixed Price Delivery Order, and no set-aside designation was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order valued at $24,161.01 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,583.90 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through March 7, 2024. The contract is a firm-fixed-price type with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is a delivery order with a ceiling value of $4,772.69, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a prescription medication. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,097.08, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of March 8, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,650.85 firm fixed-price delivery order is for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQUD7Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,980.38 firm fixed price delivery order is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical products and medical supplies to various government agencies, particularly supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables efficient procurement of essential medical commodities for military and veteran healthcare needs. This delivery order is part of that broader contracting vehicle. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/6/23 |